JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens ...
The new full visual range IOL*1 delivers exceptional distance vision2 and 14% smaller readable print size vs PanOptix3 †. 93% of patients become free from glasses at all distances.#4 ‡ TECNIS Odyssey ...
Please provide your email address to receive an email when new articles are posted on . The enVista Aspire IOL was designed to improve depth of focus from distance to intermediate vision. Most eyes ...
The new full visual range *1 IOL offers high-quality and continuous vision with unmatched range. $6,16 This will allow patients to see clearly from far to near and in between, minimizing their need ...
enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...
Lucent Vision has published a new educational resource titled “What Practice Offers Premium IOLs in Fountain Valley?” to help patients better understand their options for modern refractive surgery and ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark ...
Please provide your email address to receive an email when new articles are posted on . The decision of which type of IOL to implant in a patient is a multistep process in my practice.
Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results